Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Myriad Genetics (NASDAQ:MYGN) through any online brokerage.
Other companies in Myriad Genetics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Myriad Genetics has a consensus price target of $10.43.
The stock price for Myriad Genetics (NASDAQ: MYGN) is $5.68 last updated October 20, 2026 at 2:43 PM EDT.
There are no upcoming dividends for Myriad Genetics.
Myriad Genetics does not have any upcoming earnings scheduled.
There is no upcoming split for Myriad Genetics.
Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.